Ledger.Open graph →
SEC Form D · filed October 18, 2021

NeuroBo Pharmaceuticals, Inc

Offering
$14.0M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Jason J. Groves · Boston, MADirectorAkash J. Bakshi · Boston, MAExecRichard J. Kang · Boston, MAExec · DirectorMichael J. Salsbury · Boston, MADirectorDouglas J. Swirsky · Boston, MADirectorYeon J. Kim · Boston, MADirectorHyung H. Kim · Boston, MADirectorAndrew I. Koven · Boston, MADirectorMichael J. Salsbury · Boston, MADirectorPatrick Sakala · George Town, Cayman IslandsExec · DirectorDeborah D. Flickinger · Los Angeles, CADirectorMichael Gaubert · Dallas, TXDirectorJoshua J. Widoff · Denver, COExecItay Goren · Wilmington, DEDirectorCharlie Yue · Dallas, TXDirectorBrad Perry · Dallas, TXDirectorWilliam Hancock · DALLAS, TXDirectorVictor Whitmore · Tulsa, OKExecThomas Cahill · Miami, FLExec · DirectorMelissa Bethell · London, United KingdomDirectorHyung H. Kim · Boston, MADirectorAndrew I. Koven · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗